With box warnings

Without box warnings

Branded

Generic

2 results

arcalyst
(rilonacept)
Kiniksa Pharmaceuticals (UK), Ltd.
Usage: ARCALYST (rilonacept) is indicated for treating Cryopyrin-Associated Periodic Syndromes (CAPS) in patients 12 years and older, maintaining remission of Deficiency of Interleukin-1 Receptor Antagonist (DIRA) in patients weighing at least 10 kg, and for managing recurrent pericarditis in patients 12 years and older.
ilaris
(canakinumab)
Novartis Pharmaceuticals Corporation
Usage: ILARIS (canakinumab) is indicated for treating autoinflammatory Periodic Fever Syndromes, including CAPS, TRAPS, HIDS/MKD, and FMF; active Still's Disease in patients 2 years and older; and symptomatic treatment of gout flares in adults when other treatments are unsuitable.

Medications for Cryopyrinassociated Periodic Syndromes

arcalyst